Healthequity (HQY)

NASDAQ:HQY

HQY

Healthequity

RESEARCH TOOLSreports

Healthequity (HQY) Stock Forecast & Price Target

Compare

889 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

HQY Analyst Ratings

Strong Buy

11 Buy

1 Hold

1 Sell

Based on 13 analysts giving stock ratings to

Healthequity

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

HQY Stock 12 Month Forecast

Average Price Target

$109.42

▲(32.68% Upside)

Based on 13 Wall Street analysts offering 12 month price targets for Healthequity in the last 3 months. The average price target is $109.42 with a high forecast of $128.00 and a low forecast of $85.00. The average price target represents a 32.68% change from the last price of $82.47.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"76":"$76","129":"$129","89.25":"$89.3","102.5":"$102.5","115.75":"$115.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":128,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$128.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":109.42,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$109.42</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":85,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$85.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[76,89.25,102.5,115.75,129],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,77.93,81.78153846153847,85.63307692307693,89.4846153846154,93.33615384615385,97.18769230769232,101.03923076923077,104.89076923076924,108.74230769230769,112.59384615384616,116.44538461538463,120.29692307692308,124.14846153846153,{"y":128,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,77.93,80.3523076923077,82.77461538461539,85.19692307692308,87.61923076923077,90.04153846153847,92.46384615384616,94.88615384615386,97.30846153846154,99.73076923076923,102.15307692307692,104.57538461538462,106.99769230769232,{"y":109.42,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,77.93,78.47384615384615,79.01769230769231,79.56153846153846,80.10538461538462,80.64923076923077,81.19307692307693,81.73692307692308,82.28076923076924,82.82461538461538,83.36846153846155,83.91230769230769,84.45615384615385,{"y":85,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":109.76,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.05,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.95,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":102.81,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":102.89,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":91.06,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":88.85,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":90.71,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":94.58,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":102.41,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":91.61,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.07,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":77.93,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$128.00

Average Price Target$109.42

Lowest Price Target$85.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Alexei Gogolev

J.P. Morgan

$123

Buy

49.15%

Upside

Reiterated

03/25/26

Healthequity (HQY) Gets a Buy from J.P. Morgan

Peter Warendorf

Barclays

$110

Buy

33.38%

Upside

Reiterated

03/25/26

Barclays Sticks to Their Buy Rating for Healthequity (HQY)

George Hill

Deutsche Bank

$120→$128

Buy

55.21%

Upside

Reiterated

03/19/26

HealthEquity price target raised to $128 from $120 at Deutsche BankHealthEquity price target raised to $128 from $120 at Deutsche Bank

Alexander Paris

Barrington

$110

Buy

33.38%

Upside

Reiterated

03/18/26

HealthEquity: Strong Operational Execution and HSA Market Leadership Support Buy Rating and Upside to $110 Target

Allen Lutz

Bank of America Securities

―

Buy

―

Reiterated

03/18/26

Analysts Offer Insights on Healthcare Companies: Healthequity (NASDAQ: HQY) and Intuitive Surgical (NASDAQ: ISRG)

Stan Berenshteyn

Wells Fargo

$125

Buy

51.57%

Upside

Reiterated

03/18/26

Analysts Are Bullish on These Healthcare Stocks: Healthequity (HQY), Kestra Medical Technologies Ltd. (KMTS)

David Larsen

BTIG

$110

Buy

33.38%

Upside

Reiterated

03/18/26

Analysts Conflicted on These Healthcare Names: Incyte (NASDAQ: INCY), Hinge Health, Inc. Class A (NYSE: HNGE) and Healthequity (NASDAQ: HQY)

Daniel Perlin

RBC Capital

$110→$100

Buy

21.26%

Upside

Assigned

03/17/26

Analysts' Top Healthcare Picks: Healthequity (HQY), AbSci (ABSI)

Scott Schoenhaus

KeyBanc

$125

Buy

51.57%

Upside

Reiterated

03/05/26

KeyBanc Keeps Their Buy Rating on Healthequity (HQY)

Sean Dodge

BMO Capital

$100→$85

Hold

3.07%

Upside

Reiterated

02/24/26

HealthEquity price target lowered to $85 from $100 at BMO CapitalHealthEquity price target lowered to $85 from $100 at BMO Capital

Brian Tanquilut

Jefferies

$120→$108

Buy

30.96%

Upside

Reiterated

02/19/26

HealthEquity price target lowered to $108 from $120 at JefferiesHealthEquity price target lowered to $108 from $120 at Jefferies

Gregory Peters

Raymond James

$120→$100

Buy

21.26%

Upside

Reiterated

02/17/26

HealthEquity price target lowered to $100 from $120 at Raymond JamesHealthEquity price target lowered to $100 from $120 at Raymond James

David Roman

Goldman Sachs

$113→$89

Sell

7.92%

Upside

Downgraded

01/09/26

Goldman Sachs downgrades Healthequity (HQY) to a Sell

Constantine Davides

Citizens JMP

$117→$122

Buy

47.93%

Upside

Reiterated

12/04/25

HealthEquity price target raised to $122 from $117 at Citizens JMPHealthEquity price target raised to $122 from $117 at Citizens JMP

Steven Valiquette

Mizuho Securities

$126

Buy

52.78%

Upside

Reiterated

07/02/25

Mizuho Securities Remains a Buy on Healthequity (HQY)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Alexei Gogolev

J.P. Morgan

$123

Buy

49.15%

Upside

Reiterated

03/25/26

Healthequity (HQY) Gets a Buy from J.P. Morgan

Peter Warendorf

Barclays

$110

Buy

33.38%

Upside

Reiterated

03/25/26

Barclays Sticks to Their Buy Rating for Healthequity (HQY)

George Hill

Deutsche Bank

$120→$128

Buy

55.21%

Upside

Reiterated

03/19/26

HealthEquity price target raised to $128 from $120 at Deutsche BankHealthEquity price target raised to $128 from $120 at Deutsche Bank

Alexander Paris

Barrington

$110

Buy

33.38%

Upside

Reiterated

03/18/26

HealthEquity: Strong Operational Execution and HSA Market Leadership Support Buy Rating and Upside to $110 Target

Allen Lutz

Bank of America Securities

―

Buy

―

Reiterated

03/18/26

Analysts Offer Insights on Healthcare Companies: Healthequity (NASDAQ: HQY) and Intuitive Surgical (NASDAQ: ISRG)

Stan Berenshteyn

Wells Fargo

$125

Buy

51.57%

Upside

Reiterated

03/18/26

Analysts Are Bullish on These Healthcare Stocks: Healthequity (HQY), Kestra Medical Technologies Ltd. (KMTS)

David Larsen

BTIG

$110

Buy

33.38%

Upside

Reiterated

03/18/26

Analysts Conflicted on These Healthcare Names: Incyte (NASDAQ: INCY), Hinge Health, Inc. Class A (NYSE: HNGE) and Healthequity (NASDAQ: HQY)

Daniel Perlin

RBC Capital

$110→$100

Buy

21.26%

Upside

Assigned

03/17/26

Analysts' Top Healthcare Picks: Healthequity (HQY), AbSci (ABSI)

Scott Schoenhaus

KeyBanc

$125

Buy

51.57%

Upside

Reiterated

03/05/26

KeyBanc Keeps Their Buy Rating on Healthequity (HQY)

Sean Dodge

BMO Capital

$100→$85

Hold

3.07%

Upside

Reiterated

02/24/26

HealthEquity price target lowered to $85 from $100 at BMO CapitalHealthEquity price target lowered to $85 from $100 at BMO Capital

Brian Tanquilut

Jefferies

$120→$108

Buy

30.96%

Upside

Reiterated

02/19/26

HealthEquity price target lowered to $108 from $120 at JefferiesHealthEquity price target lowered to $108 from $120 at Jefferies

Gregory Peters

Raymond James

$120→$100

Buy

21.26%

Upside

Reiterated

02/17/26

HealthEquity price target lowered to $100 from $120 at Raymond JamesHealthEquity price target lowered to $100 from $120 at Raymond James

David Roman

Goldman Sachs

$113→$89

Sell

7.92%

Upside

Downgraded

01/09/26

Goldman Sachs downgrades Healthequity (HQY) to a Sell

Constantine Davides

Citizens JMP

$117→$122

Buy

47.93%

Upside

Reiterated

12/04/25

HealthEquity price target raised to $122 from $117 at Citizens JMPHealthEquity price target raised to $122 from $117 at Citizens JMP

Steven Valiquette

Mizuho Securities

$126

Buy

52.78%

Upside

Reiterated

07/02/25

Mizuho Securities Remains a Buy on Healthequity (HQY)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Healthequity

3 Months

xxx

Success Rate

16/24 ratings generated profit

Average Return

+5.20%

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +5.20% per trade.

1 Year

David LarsenBTIG

Success Rate

12/18 ratings generated profit

Average Return

+5.62%

Copying David Larsen's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +5.62% per trade.

2 Years

xxx

Success Rate

15/23 ratings generated profit

Average Return

+18.60%

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 65.22% of your transactions generating a profit, with an average return of +18.60% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HQY Analyst Recommendation Trends

Rating

Nov 25

Dec 25

Jan 26

Feb 26

Mar 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, HQY has received 24 Buy Ratings, 1 Hold Ratings, and 1 Sell Ratings. HQY average Analyst price target in the past 3 months is 109.42.

Each month's total comprises the sum of three months' worth of ratings.

HQY Financial Forecast

HQY Earnings Forecast

Next quarter’s earnings estimate for HQY is $1.11 with a range of $1.05 to $1.14. The previous quarter’s EPS was $0.95. HQY beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year HQY has Performed in-line its overall industry.

HQY Sales Forecast

Next quarter’s sales forecast for HQY is $351.87M with a range of $347.60M to $357.54M. The previous quarter’s sales results were $334.59M. HQY beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year HQY has Performed in-line its overall industry.

HQY Stock Forecast FAQ

What is HQY’s average 12-month price target, according to analysts?

Based on analyst ratings, Healthequity’s 12-month average price target is 109.42.

What is HQY’s upside potential, based on the analysts’ average price target?

Healthequity has 32.68% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is HQY a Buy, Sell or Hold?

Healthequity has a consensus rating of Strong Buy which is based on 11 buy ratings, 1 hold ratings and 1 sell ratings.

What is Healthequity’s price target?

The average price target for Healthequity is 109.42. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $128.00 ,the lowest forecast is $85.00. The average price target represents 32.68% Increase from the current price of $82.47.

What do analysts say about Healthequity?

Healthequity’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Streets Analysts.

How can I buy shares of HQY?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Healthequity (HQY) Stock Forecast & Price Target

HQY Analyst Ratings

HQY Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Healthequity

HQY Analyst Recommendation Trends

HQY Financial Forecast

HQY Earnings Forecast

HQY Sales Forecast

HQY Stock Forecast FAQ

Detailed List of Analyst Forecasts